Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Regenerative Medicine, Bioelectronics), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030 at a CAGR of 7.4% from 2022 to 2030.
Companies Mentioned
- BiomX
- Singota Solution
- Anima Biotech Inc.
- Ginkgo Bioworks
- Setpoint Medical Corporation
- Zymergen Inc.
- Galvani Bioelectronics
- Bico - The Bio Convergence Company
Owing to factors including the growing geriatric population, rising stem cell technology regarding the advantages of fixing damaged cells, tissues as well as organs, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics (relationship between individuals and their environment), and artificial intelligence with life science. Besides healthcare, bioconvergence is finding applications in a variety of other areas as well, including agriculture, energy, food, security, climate, and others.
The COVID-19 pandemic has significantly impacted medication research, health technology, and medical technology. The incorporation of high-tech technologies such as AI and ML into the biotech research and development sector aided in understanding the pathogen and developing drugs as well as vaccines to control the spread of the virus across the globe.
The amalgamation of advanced engineering, biology, physics, and computational sciences, has significantly increased the pace of drug development. According to the 2021 academic paper Frontiers in Medicine, advanced technologies such as AI have helped in efficient diagnosis, prognosis examination, epidemic prediction, and drug discovery for COVID-19.
With the rise in terms of acceptance of digital advancements, cloud-based solutions are likely to evolve in the pharmaceutical industry at an exponential pace. Regenerative medicine is evolving by merging expertise knowledge with life science, advanced engineering, robotics, computer science, and automation to provide elements for in-vivo repair.
Healthcare Bioconvergence Market Report Highlights
- Based on application, drug discovery dominates dominated the market in terms of the revenue share of 20.0% in 2021 and is expected to witness the fastest CAGR of 8.2% from 2022 to 2030. This is attributable to the growing frequency of a broad range of ailments (such as nervous system-related disorders, and circulatory disorders), mounting medical costs, as well as the approaching patent termination of popular drugs
- The regenerative medicine segment is likely to witness the fastest CAGR of 8.7% from 2022 to 2030 owing to its exceptional potential to treat chronic diseases such as Parkinson's disease, Alzheimer's disease, brain injury tissue repair, and to treat chronic diseases by target-oriented, and site-specific delivery of precise drugs
- In 2021, Europe dominated the market with a revenue share of 29.8%, owing to the presence of leading research institutes, hospitals, and medical centers which serve a solid basis for identifying and creating innovative medical and scientific treatments
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 90 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $121.7 Billion |
| Forecasted Market Value (USD) by 2030 | $215.2 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Report Scope and Objectives
Chapter 2 Methodology
Chapter 3 Executive Summary
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Healthcare Bioconvergence Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Healthcare Bioconvergence: Business Environment Analysis Tools
4.3.1 Porter's Five Forces Analysis
4.4 Penetration & Growth Prospect Mapping
4.5 Impact of COVID-19 on Healthcare Bioconvergence Market
Chapter 5 Healthcare Bioconvergence Market: Application Analysis
5.1 Healthcare Bioconvergence Application Market Share Analysis, 2021 & 2030
5.2 Healthcare Bioconvergence Application Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment
5.3.1 Drug Discovery
5.3.1.1 Drug Discovery Market, 2017 - 2030 (USD Million)
5.3.2 Nanorobotics For Drug Delivery
5.3.2.1 Nanorobotics For Drug Delivery Market, 2017 - 2030 (USD Million)
5.3.3 Regenerative Medicine
5.3.3.1 Regenerative Medicine Market, 2017 - 2030 (USD Million)
5.3.4 Diagnostic And Biological Sensors
5.3.4.1 Diagnostic And Biological Sensors Market, 2017 - 2030 (USD Million)
5.3.5 Bioelectronics
5.3.5.1 Bioelectronics Market, 2017 - 2030 (USD Million)
5.3.6 Engineered Living Materials
5.3.6.1 Engineered Living Materials Market, 2017 - 2030 (USD Million)
5.3.7 Optogenetics
5.3.7.1 Optogenetics Market, 2017 - 2030 (USD Million)
5.3.8 Precision Medicine
5.3.8.1 Precision medicine market, 2017 - 2030 (USD Million)
Chapter 6 Healthcare Bioconvergence Market: Regional Analysis
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
Chapter 8 KOL Commentary
For more information about this report visit https://www.researchandmarkets.com/r/acx8wj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
